Ghent University Academic Bibliography

Advanced

Chronic rhinosinusitis in Europe: an underestimated disease: a GA²LEN study

D Hastan, WJ Fokkens, Claus Bachert UGent, RB Newson, J Bislimovska, A Bockelbrink, PJ Bousquet, G Brozek, A Bruno and SE Dahlén, et al. (2011) ALLERGY. 66(9). p.1216-1223
abstract
Background: Chronic rhinosinusitis (CRS) is a common health problem, with significant medical costs and impact on general health. Even so, prevalence figures for Europe are unavailable. In this study, conducted by the GA(2)LEN network of excellence, the European Position Paper on Rhinosinusitis and nasal Polyps ((EPOS)-O-3) diagnostic criteria are applied to estimate variation in the prevalence of Chronic rhinosinusitis (CRS) for Europe. Method: A postal questionnaire was sent to a random sample of adults aged 1575 years in 19 centres in Europe. Participants reported symptoms of CRS, and doctor diagnosed CRS, allergic rhinitis, age, gender and smoking history. Definition of CRS was based on the (EPOS)-O-3 diagnostic criteria: the presence of more than two of the symptoms: (i) nasal blockage, (ii) nasal discharge, (iii) facial pain/pressure or (iv) reduction in sense of smell, for >12 weeks in the past year - with at least one symptom being nasal blockage or discharge. Results: Information was obtained from 57 128 responders living in 19 centres in 12 countries. The overall prevalence of CRS by (EPOS)-O-3 criteria was 10.9% (range 6.9-27.1). CRS was more common in smokers than in nonsmokers (OR 1.7: 95% CI 1.6-1.9). The prevalence of self-reported physician-diagnosed CRS within centres was highly correlated with the prevalence of (EPOS)-O-3-diagnosed CRS. Conclusion: This is the first European international multicentre prevalence study of CRS. In this multicentre survey of adults in Europe, about one in ten participants had CRS with marked geographical variation. Smoking was associated with having CRS in all parts of Europe.
Please use this url to cite or link to this publication:
author
organization
alternative title
Chronic rhinosinusitis in Europe : an underestimated disease : a GA(2)LEN study
Chronic rhinosinusitis in Europe : an underestimated disease : a GA2LEN study
year
type
journalArticle (original)
publication status
published
subject
keyword
SINUSES, PREVALENCE, SYMPTOMS, RHINITIS, CARE, EPIDEMIOLOGY, HEALTH-SURVEY, CHRONIC SINUSITIS, INCIDENTAL ABNORMALITIES, sinusitis, smoking, prevalence, chronic rhinosinusitis, asthma, allergic rhinitis
journal title
ALLERGY
Allergy
volume
66
issue
9
pages
1216 - 1223
Web of Science type
Article
Web of Science id
000293343000011
JCR category
ALLERGY
JCR impact factor
6.271 (2011)
JCR rank
2/23 (2011)
JCR quartile
1 (2011)
ISSN
0105-4538
DOI
10.1111/j.1398-9995.2011.02646.x
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
1243026
handle
http://hdl.handle.net/1854/LU-1243026
date created
2011-05-25 17:31:54
date last changed
2015-06-17 09:36:13
@article{1243026,
  abstract     = {Background: Chronic rhinosinusitis (CRS) is a common health problem, with significant medical costs and impact on general health. Even so, prevalence figures for Europe are unavailable. In this study, conducted by the GA(2)LEN network of excellence, the European Position Paper on Rhinosinusitis and nasal Polyps ((EPOS)-O-3) diagnostic criteria are applied to estimate variation in the prevalence of Chronic rhinosinusitis (CRS) for Europe. 
Method: A postal questionnaire was sent to a random sample of adults aged 1575 years in 19 centres in Europe. Participants reported symptoms of CRS, and doctor diagnosed CRS, allergic rhinitis, age, gender and smoking history. Definition of CRS was based on the (EPOS)-O-3 diagnostic criteria: the presence of more than two of the symptoms: (i) nasal blockage, (ii) nasal discharge, (iii) facial pain/pressure or (iv) reduction in sense of smell, for {\textrangle}12 weeks in the past year - with at least one symptom being nasal blockage or discharge. 
Results: Information was obtained from 57 128 responders living in 19 centres in 12 countries. The overall prevalence of CRS by (EPOS)-O-3 criteria was 10.9\% (range 6.9-27.1). CRS was more common in smokers than in nonsmokers (OR 1.7: 95\% CI 1.6-1.9). The prevalence of self-reported physician-diagnosed CRS within centres was highly correlated with the prevalence of (EPOS)-O-3-diagnosed CRS. 
Conclusion: This is the first European international multicentre prevalence study of CRS. In this multicentre survey of adults in Europe, about one in ten participants had CRS with marked geographical variation. Smoking was associated with having CRS in all parts of Europe.},
  author       = {Hastan, D and Fokkens, WJ and Bachert, Claus and Newson, RB and Bislimovska, J and Bockelbrink, A and Bousquet, PJ and Brozek, G and Bruno, A and Dahl{\'e}n, SE and Forsberg, B and Gunnbj{\"o}rnsd{\'o}ttir, M and Kasper, L and Kr{\"a}mer, U and Kowalski, ML and Lange, B and Lundb{\"a}ck, B and Salagean, E and Todo-Bom, A and TOMASSEN, PETER and Toskala, E and van Drunen, CM and Bousquet, J and Zuberbier, T and Jarvis, D and Burney, P},
  issn         = {0105-4538},
  journal      = {ALLERGY},
  keyword      = {SINUSES,PREVALENCE,SYMPTOMS,RHINITIS,CARE,EPIDEMIOLOGY,HEALTH-SURVEY,CHRONIC SINUSITIS,INCIDENTAL ABNORMALITIES,sinusitis,smoking,prevalence,chronic rhinosinusitis,asthma,allergic rhinitis},
  language     = {eng},
  number       = {9},
  pages        = {1216--1223},
  title        = {Chronic rhinosinusitis in Europe: an underestimated disease: a GA{\texttwosuperior}LEN study},
  url          = {http://dx.doi.org/10.1111/j.1398-9995.2011.02646.x},
  volume       = {66},
  year         = {2011},
}

Chicago
Hastan, D, WJ Fokkens, Claus Bachert, RB Newson, J Bislimovska, A Bockelbrink, PJ Bousquet, et al. 2011. “Chronic Rhinosinusitis in Europe: An Underestimated Disease: a GA2LEN Study.” Allergy 66 (9): 1216–1223.
APA
Hastan, D, Fokkens, W., Bachert, C., Newson, R., Bislimovska, J., Bockelbrink, A., Bousquet, P., et al. (2011). Chronic rhinosinusitis in Europe: an underestimated disease: a GA2LEN study. ALLERGY, 66(9), 1216–1223.
Vancouver
1.
Hastan D, Fokkens W, Bachert C, Newson R, Bislimovska J, Bockelbrink A, et al. Chronic rhinosinusitis in Europe: an underestimated disease: a GA2LEN study. ALLERGY. 2011;66(9):1216–23.
MLA
Hastan, D, WJ Fokkens, Claus Bachert, et al. “Chronic Rhinosinusitis in Europe: An Underestimated Disease: a GA2LEN Study.” ALLERGY 66.9 (2011): 1216–1223. Print.